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To the Editor: Extraintestinal 
pathogenic Escherichai coli (ExPEC) 
bacteria have the ability to cause di-
verse and serious diseases, such as 
urinary tract infections (UTIs) and 
bacteremia (1–3); incidence of bacte-
remia is increasing globally (4). The 
emergence of multidrug resistance in 
E. coli is also becoming a global con-
cern, with particular emphasis on E. 
coli sequence type (ST) 131, which 
is being increasingly reported in 
UTIs. Drug resistance is mediated by 
extended-spectrum β-lactamases (ES-
BLs), mainly of the CTX-M family, 
particularly CTX-M-15 and 14, and 
less frequently of the SHV and OXA 
families (5,6). Few studies are avail-
able regarding the characterization of 
E. coli strains causing bacteremia.
We characterized 140 E. coli iso-
lates from bacteremia patients treated 
at Nottingham University Hospital 
(Nottingham, UK) over a 5-month 
period, with the aim of developing an 
epidemiologic profile of the popula-
tion of ExPEC that causes bacteremia. 
For context, we compared the isolates 
with 125 E. coli isolates from urine 
samples collected during the same pe-
riod. Cases were selected to include 
isolates from a diverse patient group: 
patient ages ranged from 1 month to 
90 years; patient sex was evenly di-
vided between male and female; infec-
tions were community- and hospital-
associated; and suspected sources of 
infection varied. Antimicrobial drug 
susceptibility tests, PCR detection of 
ESBL genes, multilocus sequence typ-
ing using the Achtman scheme (http://
mlst.ucc.ie/mlst/dbs/Ecoli), and viru-
lence-associated gene (VAG) carriage 
screening by PCR were performed on 
isolates as described (7).
Significantly more bacteremia E. 
coli isolates than urine E. coli isolates 
were resistant to ciprofloxacin (25.7% 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	19,	No.	10,	October	2013	 1699
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vs. 8.8%; p<0.001) and cefradine 
(20.0% vs. 11.2%; p<0.05). These re-
sults were reflected in the number of 
isolates in the 2 populations display-
ing a multidrug- resistance phenotype 
(resistance to antimicrobial drugs be-
longing to >2 classes); a significantly 
higher number of multidrug-resistant 
bacteremia E. coli isolates than mul-
tidrug-resistant urine isolates were 
found (50.7% vs. 32%; p = 0.01). PCR 
screening for ESBL carriage showed 
significantly higher ESBL carriage in 
bacteremia E. coli isolates than urine 
isolates for blaSHV (15.7% vs. 5.6%; p 
= 0.008), blaCTX-M (29.3% vs. 17.6%; p 
= 0.025), and blaOXA (14.3% vs. 6.4%; 
p = 0.037). Total ESBL carriage for 
bacteremia isolates was also signifi-
cantly higher than for urine isolates 
(59.3% vs. 29.6%; p<0.001).
Multilocus sequence types were 
determined for all E. coli isolates. A 
total of 63 STs were found among the 
urine isolates (Figure, panel A); the 
highest prevalence was ST73 (n = 16, 
12.8%), followed by ST131 (n = 9, 
7.2%), ST69 (n = 9, 7.2%), ST95 (n = 
6, 4.8%), ST404 (n = 6, 4.8%), ST127 
(n = 4, 3.2%), ST141 (n = 4, 3.2%), 
and ST10 (n = 3, 2.4%). Prevalence 
patterns of STs among bacteremia E. 
coli isolates were noticeably differ-
ent (Figure, panel B). Three main STs 
were obtained. ST131 dominated (n 
= 30, 21.43%) and was significantly 
higher in prevalence than for the urine 
isolates (p<0.001). ST73 (n = 24, 
17.14%) and ST95 (n = 13, 9.29%) 
were the other 2 primary STs found. 
The 8 most prevalent STs in the bac-
teremia isolates represented 59.29% 
of the total population, whereas the 
8 most prevalent STs in the urine iso-
lates represented 45.6% of the total 
population. This finding is suggestive 
of selection of a smaller number of 
dominant STs in bacteremia.
ESBL carriage was mapped onto 
minimum-spanning trees for the 2 
isolate groups. ESBL carriage among 
urine isolates was focused on a small 
number of STs; 19 (30.16%) of the 63 
STs contained ESBL-positive isolates 
(Figure, panel A). The predominant 
ST73 group contained 18.75% ESBL-
positive isolates; the other predomi-
nant STs exhibited ESBL-positive 
isolates at the following levels: ST131 
(44.44%), ST69 (33.33%), ST95 
(50%), and ST10 (0%). In contrast, 
30 (51.72%) of the 58 STs among 
bacteremia isolates contained ESBL-
positive isolates, significantly higher 
than for the urine isolates (p = 0.016). 
At the ST level, predominant STs had 
higher ESBL carriage in the bactere-
mia isolates than in the urine isolates: 
ST131 (50%), ST73 (50%), ST12 
(75%), ST10 (100%), ST14 (50%), 
ST2278 (33.33%). ST95 (46.15%) 
and ST69 (20%) showed compara-
ble levels. These results suggest that 
ESBL drug resistance is selecting for 
dominant ExPEC bacteremia strains.
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Figure.	Minimum-spanning	trees	showing	carriage	
of	 extended-spectrum	 β-lactamases	 (ESBL)	 in	
Escherichia coli	 isolates	 from	urine	 samples	 (A)	




group.	 Lines	 between	 the	 circles	 represent	 how	
different	 their	allelic	profiles	are;	a	 line	 labeled	1	
means	the	linked	STs	differ	in	>1	of	the	7	alleles,	
which	 is	 named	 a	 single	 locus	 variant	 (SLV).	A	
cluster	of	STs	linked	by	SLVs	is	a	clonal	complex.	




To investigate whether the dif-
ferences in ST observations between 
bacteremia and urine isolates could 
be attributable to differences in vir-
ulence genes, VAGs of all isolates 
were screened by multiplex PCR. 
VAGs were found equally distributed 
across the 2 populations, with no sta-
tistically significant difference (p = 
0.675). Comparison of serum resis-
tance levels between urine and blood 
isolates also showed no phenotypic 
differences.
In conclusion, we found high lev-
els of ESBL carriage and multidrug re-
sistance in ExPEC isolates that cause 
bacteremia. A comparison with urine 
isolates provided evidence that ESBL-
mediated drug resistance appears to be 
the selective pressure in the emergence 
of dominant STs in bacteremia. Future 
research should focus on identifying 
if prolonged antimicrobial drug treat-
ment in bacteremia patients is leading 
to this selection.
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Virus during Winter, 
Germany
To the Editor: Schmallenberg 
virus (SBV), an orthobunyavirus, 
emerged in northern Europe in 2011 
(1). SBV infection causes transient fe-
ver, diarrhea, and a reduced milk yield 
in adult ruminants but, most notably, 
stillbirths and severe malformations 
in lambs and calves (2). Insect vectors 
play an essential role in transmission; 
the viral genome has been detected in 
various field-collected biting midges 
(Culicoides spp.) (3,4).
During autumn 2012 and winter 
2012–2013, blood samples were taken 
at several times from individual sheep 
on a farm located in the German fed-
eral state of Mecklenburg–Western 
Pomerania. The farm is surrounded 
by agricultural fields and meadows. 
Approximately 1,000 ewes and their 
lambs, a dog, and some cats were kept 
on the farm; most of the animals are 
outdoors year-round. Only dams with 
>2 lambs are housed in open stabling 
in December and January. The dung 
is regularly cleared away and stored 
≈10 m from 1 of the stable entrances. 
Repellents or insecticides were not ap-
plied in the monitored period. Blood 
samples were taken in September 2012 
and in January and February 2013 and 
analyzed by an SBV-specific real-time 
quantitative reverse transcription PCR 
(RT-qPCR) (5) and by an SBV anti-
body ELISA (ID Screen Schmallen-
berg virus Indirect; IDvet; Montpelli-
er, France) by using the recommended 
cutoff of 50% relative optical density 
as compared with the positive control 
(sample-to-positive ratio [S/P]).
In September 2012, blood sam-
ples from 60 sheep tested negative by 
the SBV antibody ELISA. Moreover, 
fetal malformations of the brain, spi-
nal cord, or skeletal muscle, which 
might have suggested a previous 
SBV-infection of the dam, were not 
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